A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States

BACKGROUND: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, progressive autoimmune disease causing peripheral nervous system dysfunction. Guidelines recommend immunoglobulin (IG) therapy as an immunomodulatory agent in CIDP. Drawbacks and unmet needs with intravenous immunoglobul...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallick, Rajiv, Carlton, Rashad, Van Stiphout, Joris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910243/
https://www.ncbi.nlm.nih.gov/pubmed/36757567
http://dx.doi.org/10.1007/s41669-023-00386-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910243/
https://www.ncbi.nlm.nih.gov/pubmed/36757567
http://dx.doi.org/10.1007/s41669-023-00386-2

Ejemplares similares